Publication:
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study

dc.contributor.authorMurri, Mora
dc.contributor.authorLeiva, Isabel
dc.contributor.authorGómez-Zumaquero, Juan Miguel
dc.contributor.authorTinahones, Francisco J
dc.contributor.authorCardona, Fernando
dc.contributor.authorSoriguer, Federico
dc.contributor.authorQueipo-Ortuño, María Isabel
dc.contributor.authoraffiliation[Murri,M; Cardona,F; Queipo-Ortuño,MI] Biomedical Research Laboratory, Hospital Universitario Virgen de la Victoria (FIMABIS), Málaga, Spain. [Leiva,I] Pediatric Endocrinology Service, Carlos Haya Materno Infantil Hospital, Málaga, Spain. [Gómez-Zumaquero,JM] Molecular Biology Laboratory, Civil Hospital (IMABIS foundation), Málaga, Spain. [Tinahones,FJ; Cardona,F; Queipo-Ortuño,MI] CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. [Soriguer,F] Endocrinology and Nutrition Service, Carlos Haya Hospital, Málaga, Spain. [Soriguer,F] CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. [Tinahones,FJ] Endocrinology and Nutrition Service, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
dc.date.accessioned2024-03-05T12:46:45Z
dc.date.available2024-03-05T12:46:45Z
dc.date.issued2013-02
dc.description.abstractBackground: A recent study using a rat model found significant differences at the time of diabetes onset in the bacterial communities responsible for type 1 diabetes modulation. We hypothesized that type 1 diabetes in humans could also be linked to a specific gut microbiota. Our aim was to quantify and evaluate the difference in the composition of gut microbiota between children with type 1 diabetes and healthy children and to determine the possible relationship of the gut microbiota of children with type 1 diabetes with the glycemic level. Methods: A case-control study was carried out with 16 children with type 1 diabetes and 16 healthy children. The fecal bacteria composition was investigated by polymerase chain reaction-denaturing gradient gel electrophoresis and real-time quantitative polymerase chain reaction. Results: The mean similarity index was 47.39% for the healthy children and 37.56% for the children with diabetes, whereas the intergroup similarity index was 26.69%. In the children with diabetes, the bacterial number of Actinobacteria and Firmicutes, and the Firmicutes to Bacteroidetes ratio were all significantly decreased, with the quantity of Bacteroidetes significantly increased with respect to healthy children. At the genus level, we found a significant increase in the number of Clostridium, Bacteroides and Veillonella and a significant decrease in the number of Lactobacillus, Bifidobacterium, Blautia coccoides/Eubacterium rectale group and Prevotella in the children with diabetes. We also found that the number of Bifidobacterium and Lactobacillus, and the Firmicutes to Bacteroidetes ratio correlated negatively and significantly with the plasma glucose level while the quantity of Clostridium correlated positively and significantly with the plasma glucose level in the diabetes group. Conclusions: This is the first study showing that type 1 diabetes is associated with compositional changes in gut microbiota. The significant differences in the number of Bifidobacterium, Lactobacillus and Clostridium and in the Firmicutes to Bacteroidetes ratio observed between the two groups could be related to the glycemic level in the group with diabetes. Moreover, the quantity of bacteria essential to maintain gut integrity was significantly lower in the children with diabetes than the healthy children. These findings could be useful for developing strategies to control the development of type 1 diabetes by modifying the gut microbiota.
dc.description.sponsorshipThis work was partially funded by a grant from CIBER, CB06/03/0018 of the Instituto de Salud Carlos III to MM, FC, FJT and MIQO; the Instituto de Salud Carlos III, Madrid, Spain (CP07/0095) to FJT; and the Servicio Andaluz de Salud, Andalucía, Spain (PI0696/2010) to FJT.
dc.identifier.doi10.1186/1741-7015-11-46
dc.identifier.e-issn1741-7015es_ES
dc.identifier.journalBMC medicinees_ES
dc.identifier.otherhttp://hdl.handle.net/10668/916
dc.identifier.pubmedID23433344es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18887
dc.language.isoeng
dc.publisherBioMed Central (BMC)
dc.relation.publisherversionhttp://www.biomedcentral.com/1741-7015/11/46/abstractes
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectButyrate-producing bacteria
dc.subjectGlycemic level
dc.subjectGut integrity
dc.subjectGut microbiota
dc.subjectGut permeability
dc.subjectHbA1c level
dc.subjectLactic acid-producing bacteria
dc.subjectMode of delivery
dc.subjectMucin
dc.subjectPCR-DGGE
dc.subjectType 1 diabetes
dc.subjectPermeabilidad
dc.subjectÁcido Láctico
dc.subjectHemoglobina A Glucosilada
dc.subjectNiño
dc.subjectIntestino
dc.subjectDiabetes Mellitus Tipo 1
dc.subjectÁcido Butírico
dc.subject.meshDiabetes Mellitus
dc.subject.meshDiabetes Mellitus, Type 1
dc.subject.meshButyric Acids
dc.subject.meshHemoglobin A, Glycosylated
dc.subject.meshLactic Acid
dc.subject.meshMucins
dc.subject.meshBacteria
dc.subject.meshBifidobacterium
dc.subject.meshHumans
dc.subject.meshIntestines
dc.subject.meshChild
dc.subject.meshPermeability
dc.subject.meshBiota
dc.subject.meshCase-Control Studies
dc.titleGut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files